Facing the critical health challenges of our era, iMetabolic Biopharma stands at the forefront of a medical revolution. Our mission is clear, to tackle the growing crisis of obesity-related comorbidities head-on. We're pioneering the future of healthcare with our groundbreaking TechBio AI technology.
This proprietary approach doesn't just enhance the discovery and development of therapeutics—it redefines it.
Dr. Urban A. Kiernan
Our patent-pending technology-powered iPlatform removes roadblocks that make drug development slow, expensive,
and inefficient.
Our computational approach uses in-silico therapeutic discovery and molecular design to improve traditional biotechnology, creating economic & time-saving advantages to drug discovery. This is the value that TechBio offers to you and your loved ones.
Our revolutionary approach landed us key strategic partnerships, including Amazon Web Services, Ligand Pharmaceuticals,
and OmniAb.
iMBP is also proud to be part of the McDermott Will & Emery LEAP program for corporate legal counsel.
Together, with a group of experienced advisors and executive team, our future has never been brighter.
Together, we can be the next stage in developing a revolutionary approach to drug discovery.
We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.